Argus Research Highlights LongTerm Growth Potential for Applied Materials Jobless Claims Decline to Lowest Level Since MidMay IndiaChina Border Talks Constructive Dialogue Could Ease Geopolitical Strains and Support Regional Market Sentiment Rising Inflation Pressures Extend Beyond Energy Services and Shelter Costs Reaccelerate Tesla Debuts Full SelfDriving Supervised in China as Local EV Competition Intensifies Sugar Prices Retreat Amid Crude Oil Slump EIKN Q1 2026 Earnings EPS Miss of 38 Amid PreRevenue Stage Stock Drops 9 ADUR Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment ALCO Q1 2026 Earnings Robust EPS Beat on Strong Operational Execution MLI Q1 2026 Earnings Strong Earnings Beat as EPS Surges Past Estimates LXP Industrial Trust Q1 2026 Earnings Missed EPS Estimate as Negative Earnings Reported DHIL Q1 2025 Earnings EPS of 323 Reported Amidst Market Uncertainty Soren Acquisition Corp SORN Holds Steady at 992 Amid Low Volatility BDCIW Holds Steady at 045 as Trading Range Consolidates Fastly Inc Surges 78 as Momentum Builds Toward Key Resistance Brookfield Infrastructure Corporation BIPC Navigating a Modest Pullback Amid Key Levels Nayax Ltd NYAX Gains 184 as Stock Approaches Key Resistance at 7946 IRM Q1 2026 Earnings Strong EPS Beat Highlights Resilient REIT Performance OneSpan OSPN Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Execution VEL Q1 2026 Earnings EPS Beats Estimates but Stock Dips 217 NUTX Q1 2026 Earnings EPS Surges Past Estimates by 31 as Profitability Improves WHLRL Q2 2024 Earnings Unanticipated EPS Surge Amid Limited Disclosure Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline South Korea Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Strife PCRX Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance Gores Holdings X GTEN Hovers Near 1034 as Mild Selling Pressure Keeps Stock Flat PHVS Q1 2026 Earnings NarrowerthanExpected Loss Despite No Revenue Stock Down MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline RNTX Q1 2026 Earnings Narrowed Loss Beats Estimates as Rein Therapeutics Advances Pipeline SES AI Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite WiderThanExpected Loss OVID Q1 2026 Earnings Narrower Loss and No Revenue Mark a Quiet Quarter for the Biotech ZBIO Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Pipeline GEG Q1 2026 Earnings Substantial EPS Miss Triggers Stock Decline